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Abstract
The aim of this study was to test the hypothesis that hepatic vitamin C (VC) levels in VC deficient mice rescued with
high doses of VC supplements still do not reach the optimal levels present in wild-type mice. For this, we used a
mouse scurvy model (sfx) in which the L-gulonolactone oxidase gene (Gulo) is deleted. Six age- (6 weeks old) and
gender- (female) matched wild-type (WT) and sfx mice (rescued by administering 500 mg of VC/L) were used as the
control (WT) and treatment (MT) groups (n = 3 for each group), respectively. Total hepatic RNA was used in triplicate
microarray assays for each group. EDGE software was used to identify differentially expressed genes and
transcriptomic analysis was used to assess the potential genetic regulation of Gulo gene expression. Hepatic VC
concentrations in MT mice were significantly lower than in WT mice, even though there were no morphological differ-
ences between the two groups. In MT mice, 269 differentially expressed transcripts were detected ( twice the differ-
ence between MT and WT mice), including 107 up-regulated and 162 down-regulated genes. These differentially
expressed genes included stress-related and exclusively/predominantly hepatocyte genes. Transcriptomic analysis
identified a major locus on chromosome 18 that regulates Gulo expression. Since three relevant oxidative genes are
located within the critical region of this locus we suspect that they are involved in the down-regulation of oxidative ac-
tivity in sfx mice.
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Introduction
Oxidative stress is a major pathogenic event associ-
ated with nearly all chronic liver disorders ranging from
hepatitis to cancer (Padayatty et al., 2003; Briley et al.,
2006; Chen et al., 2007). Consequently, antioxidants, such
as vitamin C (VC), are widely used as therapeutic agents.
However, the precise mechanism of antioxidant action is
still unclear and the role of VC in oxidative stress is still
controversial (Bader et al., 2007; Besaratinia et al., 2007).
HumanslacktheabilitytosynthesizeVCandobtainthisvi-
tamin primarily from food. VC deficiency in humans leads
to scurvy, which is still occasionally encountered in some
parts of the world (Burk and Molodov, 2007; Larralde et
al., 2007). A study of the long-term effects of VC defi-
ciency in the liver using these rare scurvy patients is practi-
cally impossible, especially at the molecular level, since it
would require liver tissue. The alternative is to use animal
models for such studies.
Traditionally, rodents have been used to investigate
the effects of VC, particularly through VC-deficient mod-
els. The spontaneous bone fracture (sfx) mouse (Beamer et
al., 2000) is a useful model because it lacks the gene for
L-gulonolactone oxidase (Gulo), a key enzyme in the
ascorbic acid (AA) synthesis pathway (Jiao et al., 2005).
Sfx mice are derived from an inbred strain of Balb/c mice
and therefore have a Balb/c genomic background, with the
key difference being that they possess the mutated gene for
Gulo.ThemutationforGuloisinheritedasarecessivegene
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Research Articleand produces spontaneous bone fracture(s) 6-8 weeks after
birth. Sfx mice were initially considered as a model for
stage-specific bone growth failure and fracture (Beamer et
al.,2000).Basedonroughmappingdataobtainedfrom100
sfx F2 mice we found that chromosome 14 contains an
~38 kb deletion of genomic DNA that includes the entire
Gulogene(Jiaoetal.,2005).Furtherstudiesconfirmedthat
this deletion is responsible for the bone and tissue disease
phenotypes in these mice (Beamer et al., 2000; Jiao et al.,
2005; Yan et al., 2007), which suggests that this deletion
has a wide range of effects in different mouse organs.
The administration of VC has been used to rescue
VC-deficient mice in various studies, although the amount
required varies considerably. For example, Yazama et al.
(2006) used a VC concentration of 330 mg/L in drinking
water and suggested that this ameliorated the VC defi-
ciency in Gulo-/- mutant mice. Wang et al. (2007), in a
study of the effects of VC on liver damage in lead-exposed
mice, used VC doses of 140, 420 and 1260 mg kg
-1 body
weight together with vitamin B1 (10, 30 and 90 mg kg
-1)i n
a3x3factorial design. These authors concluded that the
most effective combination was 420 mg of VC kg
-1 and
10 mg of vitamin B1 kg
-1. However, since the mice used in
thisstudywerewildtype,theywerealreadyproducingVC.
In a study in which the gastric lesions and Th1 immune re-
sponses to H. pylori were compared in VC-deficient
B6.129P2-Gulo(-/-) mice supplemented with a low
(33 mg/L) or high (3,300 mg/L) concentration of VC in the
drinking water, Lee et al. (2008) observed that VC did not
protect Gulo(-/-) mice from developing H. pylori-induced
premalignant gastric lesions, despite the high concentra-
tions of VC achieved in plasma and gastric tissue.
InviewofthewidespreaduseofVCasanantioxidant
(Al-Shamsi and Amin, 2006; Bader et al., 2007; Besara-
tinia et al., 2007; Montecinos et al., 2007; Plantinga et al.,
2007; Siriwardena et al., 2007), it is important to under-
stand the molecular mechanisms of this molecule in liver.
Since, in rodents, VC is synthesized in the liver and trans-
ported to other parts of the body, the hepatic content of VC
is critical in assessing whether the body has sufficient VC.
Inthepresentwork,wehypothesizedthatalthoughVCsup-
plements in previous studies successfully rescued mutant
mice with a seemingly normal phenotype, the hepatic VC
content of these mice was still below the optimal level
found in wild type mice. Indeed, as shown here, even with
500 mg of VC/L in the drinking water, the hepatic content
ofVCinsfxmicewasstillnotnormal.Asaresultofinsuffi-
cient hepatic VC, sfx mice had a different gene expression
profile compared to wild type mice.
Materials and Methods
Animals
Heterozygoussfx/+micewereobtainedfromJackson
Laboratories. Homozygous sfx/sfx mice were produced by
intercrossing the heterozygous sfx/+ mice at the University
of Tennessee Health Science Center (UTHSC). Experi-
mental procedures for this study were approved by the In-
stitutional Animal Care and Use Committee at UTHSC.
Normal and sfx littermates produced from the same hetero-
zygous parental pair were used in the mutation screening.
Threesix-week-oldfemalesfxmiceandthreeage-andgen-
der-matchedWTmicewereusedforthemicroarrayassays
and RT-PCR. Additional WT and sfx mice (n = 20) were
used to measure VC levels. The mice were handled accord-
ing to a protocol described elsewhere (Jiao et al., 2005).
When six weeks old, the mice were sacrificed and tissue
sampleswereimmediatelyobtainedandpreservedinliquid
nitrogen.
Vitamin C test
Prior to the vitamin C test, the mice were genotyped
using a pair of primers (forward: TGAGGCAAACATT
GGAGATG, reverse: CCCCATACCATAACCAGCAG)
flanking exon 2 of the Gulo gene. Subsequently, three ho-
mozygous sfx/sfx mice were housed in the same animal
room on the same cartridge with three +/+ BALB/cBy
mice.Allofthemicewerefedthesamefoodexceptthatthe
sfx/sfx mice received 500 mg of VC/L in their drinking wa-
ter. Plasma and hepatic VC levels were measured by the ,
'-dipyridyl method, as described by Kutnink et al. (1987).
Statistical analysis was done using an Excel t-test, with
p < 0.05 indicating significance.
DNA and RNA extraction
Genomic DNA was extracted from the livers of WT
and sfx mice using a commercial kit (Qiagen, CA) accord-
ing to the manufacturer's instructions. DNA quality and
quantity were assessed spectrophotometrically (Eppendorf
photometer, Eppendorf Scientific Inc., Westbury, NY) af-
ter which the DNA was used for large scale mutational
screening. RNA was extracted from livers using Trizol re-
agent (Invitrogen, CA) (Yan et al., 2007). Total RNA was
purified using the RNeasy MinElute cleanup kit (Qiagen).
RNA quality and integrity were checked with an Agilent
Bioanalyzer.
Microarray analysis
Total RNA was isolated from the livers of three WT
mice and three sfx mice treated with VC. Subsequently,
200 ng of high-quality RNA with a RIN (RNA Integrity
Score) number of more than 7 was used to generate cDNA
and cRNA using an Illumina
® TotalPrep RNA amplifica-
tion kit (Ambion). From each of the six samples, 1.5 go f
cRNA was hybridized overnight to the Mouse-6 v1B
BeadChip in a multiple step procedure, according to the
manufacturer's instructions. The chips were washed, dried
andscannedonaBeadArrayReader(Illumina,CA)andthe
raw data were generated using BeadStudio 2.3.41 software
(Illumina).
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method using BeadStudio software. After p value assess-
ment (p < 0.05) (Lee et al., 2009) and filtering for fold
changes=2,statisticalanalysiswasdoneusingEDGEsoft-
ware (Vollrath et al., 2009) to identify differentially ex-
pressed genes that were then used for hierarchical and
functional clustering with Cluster/TreeView and bioinfor-
matics DAVID tools, respectively. Genes were considered
to be differentially expressed when the difference in ex-
pression between the two groups was greater than two fold
(Schena et al., 1995; Gu et al., 2003).
Quantitative RT-PCR
The expression levels of 9 genes were assessed by
end-point RT-PCR. These genes were selected based on
their fold increase in expression and possible relevance to
the Gulo pathway. Total RNA was isolated from age- and
sex-matched WT and sfx mice. Reverse transcription and
PCR were done using a one-step RT-PCR kit (Invitrogen)
asrecommendedbythemanufacturer.Thespecificprimers
for the selected genes are shown in Table 1. The reactions
were done in 50 L containing 4 ng of total RNA/L and
0.2 M of sense and anti-sense primers (final concentra-
tions). cDNA synthesis and pre-denaturation were done us-
ing one cycle of 50 °C for 40 min and 94 °C for 2 min,
followed by PCR amplification with 33 cycles of 94 °C for
30 s, 54-58 °C for 36 s and 72 °C for 2 min. The PCR prod-
uctswereanalyzedbyelectrophoresisin2.0%agarosegels.
Quantitative analysis of the PCR products was done using
Scion Image software.
Tanscriptome mapping
Transcriptome mapping done with Genenetwork
software was used to identify the chromosomal regions
containing genes that affect the expression of Gulo. Gene
expression data from the livers of 46 recombinant inbred
(RI) mice derived from strains C57BL/6J and DBA/2
(BXD)wereusedinthisanalysis,whichinvolvedthreema-
jor steps. First, Gulo was identified from the probes used to
detect liver-specific gene expression in BXD RI strains.
Second, interval mapping was done to establish Gulo link-
age maps for the entire genome. Permutations of 1000 tests
wereusedtoassessthestrengthandconsistencyofthelink-
ages. Third, the maps determined in the previous step were
reassessed by focusing on the major locus identified by
whole genome mapping.
Results
Body weight gain in sfx mice supplemented with
dietary VC
sfx mice given supplementary VC (500 mg/L) in the
drinking water did not develop spontaneous fractures.
Bodyweightgaininsfxmicewasnotsignificantlydifferent
from that of WT mice (Figure 1A). However, the VC con-
centration in sfx mice was significantly lower than in nor-
mal WT mice (Figure 1B). Since previous work has shown
that various organs of sfx mice develop abnormally (Beam-
eretal.,2000;Jiaoetal.,2005)wealsoexaminedtheinflu-
ence of VC on the weight of selected organs in WT and sfx
mice. Table 2 shows that there were no significant differ-
ences in the organ weights of WT and sfx mice.
Hepatic VC level in treated sfx mice
Figure2showsthatthehepaticVClevelintreatedsfx
micewassignificantlylowerthaninnormalWTmice.This
finding indicates that the concentration of VC (500 mg/L)
in the drinking water was not sufficient to restore hepatic
VC levels to normal in sfx mice.
Differential gene expression in livers from
VC-treated mice
After normalizing the data using the Cubic spline al-
gorithm with BeadStudio, the data from the three normal
and VC-treated mice were coherent for each group (Figu-
re 2). In general, the expression profile in VC-treated sfx
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Table 1 - Primers for the different genes studied by real-time PCR.
Gene PCR product size (bp) Forward primer Reverse primer
Fgf21 368 TTCAAATCCTGGGTGTCAAAG CAGGAAGAGTCAGGACGCATA
Jun 319 TCCTGCCCGTGTTTGTAAAT CAGTCTGGACTTGTGTGTTGC
Birc5 321 CAGATCTGGCAGCTGTACCTC TGCAATTTTGTTCTTGGCTCT
Mdm2 340 CCAGCATTTTCAGCTTTTTGT CAAAGCTATCCTTCGCTTCCT
Trp53 305 CGTAAACGCTTCGAGATGTTC GCTGAGCCCTAGCTACAAGGT
Gulo 329 TTCTTCTTCTGGCTGCTGTTC GTCTCATAGGCCAGCCAGTAA
Cth 366 GCACCAACAGGTACTTCAGGA AACGAAGCCGACTATTGAGGT
Cfhl1/Cfhr1 358 TCTGTCGCCTGTTGCTCTTAG CCTTGATTGCAGACCACTTGT
Cyp3a41 337 TTTGATGGTCAAATGCCTCTC TGCTGGTGATCACATCTATGC
Map2k6 330 CTACCTGGTCGACTCTGTTGC GGATGTTGCATAAGCTCTGGA
Gapdh 533 GGGTGGAGCCAAACGGGTC GGAGTTGCTGTTGAAGTCGCAmice was greatly improved in relation to none VC-treated
mice. In our previous comparison between VC- deficient
and WT mice (Jiao et al., 2007), we detected 398 differen-
tially expressed genes in a total of 12,000 mouse tran-
scripts. In this study, we only detected 269 differentially
expressedgenesinatotalof47,000oligonucleotideprobes,
the latter corresponding to a total of 23,000 well character-
ized genes. The ratio of differentially expressed genes was
30 vs. 86 per gene (or 174.7 per probe) for the current study
vs.thepreviousstudy.Furthermore,thedegreeofchangein
these genes in the current study was much smaller than in
our previous investigation, i.e., 1.7-fold change vs. 4.1-fold
change, respectively. The altered expressions levels of ma-
jor genes in VC deficiency sfx mice have been corrected
into normal levels in VC-treated sfx mice. For example, the
expression levels of major urinary protein (Mup) genes in
VC deficiency sfx mice were significantly lower than that
of the wild type in our previous study (Yan et al., 2007);
howeverinourcurrentstudywedidnotfindsignificantdif-
ferencebetweenthosegenesinVC-treatedsfxmiceandthe
wild type. After detecting significant p values (< 0.05) and
filtering to remove genes with = 2-fold change in expres-
sion (this cutoff value was chosen based on published stud-
ies: Shahan et al., 1987; Schena et al., 1995; Gu et al.,
2003), EDGE software detected 269 differentially ex-
pressed genes out of a total of 47,000 oligonucleotide
probes, corresponding to > 23,000 well-characterized
genes and > 23,000 ESTs or predicted genes. Of these 269
genes, 107 were up-regulated and 162 were
down-regulated (Supplementary material, Table S1). Hier-
archical and functional clustering of the changes in gene
expression using Cluster/TreeView identified genes that
were differentially expressed in the two groups. Overall,
there was a decrease in the expression of genes associated
with signaling and protein binding, but an increase in those
associated with biosynthesis activity (Table 3).
Down-regulation of target genes involved in the
regulation of MAPK signaling
Since VC is a well-known antioxidant, we examined
the gene expression levels of mitogen-activated protein
kinase (MAPK) signaling in the liver. We found that a
group of genes related to a stress-activated protein kinase
(Sapks) pathway was down-regulated (Figure 3A). These
genes included dual-specificity phosphatase (Dusp)3 ,8
and 10, growth arrest- and DNA damage-inducible gene
gadd45, beta (Gadd45b), fibroblast growth factor 21
(Fgf21) and oncogene jun (Jun). Dusp 3 suppresses T-cell
receptor (TCR)-induced activation of Erk2 and Jnk in the
MAPK signaling pathway. Consequently, expression of
Jun is also decreased by Dusp 3. Gadd45b may mediate ac-
tivation of the p38/Jnk pathway, via Mtk1, in response to
environmental stress (Takekawa et al., 2002; Chi et al.,
2004). Fgf21 treatment of mouse adipocytes is associated
withphosphorylationofFrs2,adockingproteinlinkingFgf
receptors to the MAPK pathway (Kharitonenkov et al.,
2005; Wente et al., 2006). Surprisingly, there were no
down-regulated liver-specific genes in VC-treated sfx
mice.
Up-regulation of liver-specific genes in VC-treated
sfx mice
Among the genes with altered expression, a group of
genes with important functions in several diseases was
found to be up-regulated (Figure 3B). Coagulation factor
VIII (F8) was up-regulated in VC-treated sfx mice. An F8
deficiency causes the bleeding disorder known as hemo-
philia A. Individuals develop a variable phenotype consist-
ing of hemorrhaging in joints and muscles, easy bruising,
and prolonged bleeding from wounds. Bleeding is one of
theconsequencesofscurvycausedbyaVCdeficiency.The
factor h-related gene 1 (Cfhl1) has recently been associated
with a decreased risk of age-related macular degeneration
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Figure 1 - Body weight (A) and hepatic VC concentration (B) in WT and
VC-treated sfx mice. There were no significant differences in body weight
between the two groups, but vitamin C concentration was lower in sfx
mice. The columns represent the mean  SD of 10 mice per group.
Table 2 - Organ weights (in grams) in seven-week-old WT Balb/c mice
and VC-treated sfx mice.
Organs Balb/c mice Sfx mice with VC (500 mg/L) N p
Thymus 0.082  0.011 0.081  0.017 5 0.4578
Spleen 0.106  0.008 0.086  0.005 5 0.0008
Liver 1.013  0.116 0.989  0.083 5 0.3581
Heart 0.133  0.024 0.129  0.021 5 0.4142
Lung 0.130  0.013 0.128  0.005 5 0.3509
Kidney 0.274  0.032 0.250  0.025 5 0.1159
Values (in grams) are the mean  SD of the number of mice indicated.
P values are for sfx mice compared to WT Balb/c mice.390 Gene expression in wild-type vs. Gulo-deficient mice
Figure2-MajorclustersofdifferentiallyexpressedgenesinliversofVC-treatedsfxmice.Threemajorclusterswithacorrelationcoefficient(r)0.9and
more than 10 transcripts were identified. The probe-to-transcript hybridization signal intensity is color-coded from low (green) to high (red). Genes with
the same or similar color have the same or similar expression levels. The relative fold change for a transcript can be estimated from the color scale at the
bottom of the figure.
Table 3 - Genes with altered expression in VC-treated sfx mice based on microarray analysis.
Change Category Gene number p value Genes affected*
Down-regulated Signaling 19 1.40E-04 Upk3b, 17rb, Smpd1, Ly6d, Edn1, Gp5, Col1a2, Gdf15, fbln1, Lamb3, Htra3,
Fgf21, Inhbe, Lrfn3, Chrna2, Gfra3, Cxcl13, Gpr172b, Bglap-rs1
Extracellular
region
23 5.50E-03 Mesdc2, Il17rb, Ly6d, Edn1, 9430028L06Rik, Gp5, Col1a2, Fbln1, Gdf15,
Oscar, Cldn9, Adamts9, Fgf21, Htra3, Inhbe, Lamb3, Chrna2, Gfra3,
1110028A07Rik, Cxcl13, Gpr172b, Bglap-rs1, Slc13a2
Protein binding 27 5.40E-03 Gadd45b, Cidec, Il17rb, Edn1, Trim6, Cldn9, Inhbe, Zfp295, Gfra3, Synpo, Meig1,
Birc5, Plscr2, Jun, Svil, Gp5, 2610301F02Rik, Gdf15, Fbln1, Dtnb, Lamb3, Fgf21,
Htra3, Myom1, Nolc1, Cxcl13, Mdm2
Development 17 2.40E-03 Gadd45b, Mesdc2, Gtf2ird1, Edn1, Jun, 2610301F02Rik, Epb4.1l5, Htra3, Lor,
Cbfa2t3h, Adra1a, Cxcl13, Birc5, Foxo1, Bglap-rs1
Membrane 21 8.60E-04 Upk3b, Il17rb, Ly6d, 9430028L06Rik, Plscr2, Gp5, Svil, Evc2, Mas1, Cpt1b,
Cldn9, Gulo, Trpv2, lrfn3, Chrna2, Myom1, Gfra1a, Elovl3, Gpr172b, Slc132
Up-regulated Nucleotide
binding
17 6.30E-04 Hspd1, Gna12, 1810048P08Rik, Als2cr2, BC034204, Map2k6, Igf2bp3, Rab5b,
Ntrk2, Snrpa, Mthfd1, Nme4, Eef2, Eif4a2, Matr3, Prkcn, BC034507
Biosynthesis 12 1.90E-03 Inhbb, Cth, B3galt3, Smyd1,Tyms, Dct, Umps, Mthfd1, Nme4, Eif4a2, Eef2, Nsdhl
Membrane 19 1.20E-03 Gna12, Nsdhl, Slc2a2, Prss8, Aqp8, Mmd2, Ptch1, Dsg2, Prei3, Jam2, Praf2,
Tmed3, B3galt3, Ntrk2, Prom1, Ceacam1, Atp6ap2, Dct, Cyp3a41
Purine nucleo-
tide binding
14 4.50E-03 Hspd1, Gna12, 1810048P08Rik, Als2cr2, BC034204, Map2k6, Rab5b, Ntrk2,
Mthfd1, Nme4, Eef2, Eif4a2, Prkcn, BC034507
*The expression of genes marked in bold was also analyzed by quantitative RT-PCR.(Venables et al., 2006) whereas the cystathionine gamma-
lyase (Cth) gene is important for transforming cystathio-
nineintocysteineintheliver.Cytochromep450,subfamily
IIIa,polypeptide41(Cyp3a41)isafemale-specificisoform
that is predominantly expressed in the liver (Sakuma et al.,
2002). Estrogen signaling is not responsible for the female
specificity of Cyp3a41, but its expression level is regulated
by growth hormone (GH) signaling (Jarukamjorn et al.,
2006,2007).However,femalesfxmicesuppliedwithsmall
amountsofVChaveanincreasedlevelofCyp3a41.Argini-
nosuccinate synthetase 1 (Ass1) is the major lipid A-inte-
racting protein in the liver (Satoh et al., 2006).
Semi-quantitative RT-PCR confirmation of
microarray data
Although three WT and VC-treated sfx mice were
used for the microarray experiments systematic errors may
have biased the overall results. To confirm the validity of
our findings, RT-PCR was done for nine genes: three liver-
specific genes (Cth, Cth11 and Cyp3a41) and mitogen-
activated protein kinase 6 (Map2k6) were used as up-regu-
latedgenes,whereastwoMAPKpathwaygenes(Fgf21and
Jun) and three apoptosis related genes (Birc5, Mdm 2 and
Trp53) were used as down-regulated genes. GAPDH and
Gulo were used as positive and negative controls, respec-
tively. Figure 4 shows the electrophoretic profile of the
RT-PCR products. Eight of the nine genes showed PCR
amplification and confirmed the microarray results. The
only exception was Trp53, which the microrarray data
showed as being up-regulated 1.4-fold, while the RT-PCR
showedthatitwasdown-regulated(Chenetal.,2009).Cth,
Cth11andCyp3a41wereallup-regulatedinthemicroarray
analysis (Figure 3) and this was confirmed by RT-PCR
(Figure4).Fgf21andJunweredown-regulatedinRT-PCR
(Figure 4), in agreement with the microarray data (Figure
3). Map2k6 was up-regulated 4.6-fold in the microarray as-
say, whereas RT-PCR revealed a lower amplification than
in WT mice. Birc5 and Mdm 2 were down-regulated 2.4-
and 2.1-fold, respectively, in the microarray assay, and
their amplification by RT-PCR was also lower than in WT
mice.
Transcriptomic loci and genes for oxidative proteins
that regulate Gulo
Transcriptome mapping using data for gene expres-
sion in the livers of 46 RI mice led to the identification of
two loci involved in regulating Gulo gene expression (Fig-
ure 5A). The major transcriptome locus was located on
chromosome 18 (Figure 5A). Examination of the genes in
the peak region between 13 Mbp and 23 Mbp identified 20
transcripts (Figure 5B). Investigation of the potential func-
tion of these genes identified three important oxidative-
related genes, namely, transthyretin, cadherin 2 and
aquaporin 4. These three genes were located in the critical
region of the locus (Figure 5B). This finding suggests that
the down-regulation of any or all of these three oxidative
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Figure 3 - Gene expression in WT Balb/c mice and VC-treated sfx mice
based on microarray analysis. Down-regulation of genes involved in
MAPK signaling (A) and up-regulation of liver-specific genes (B) in
VC-treated sfx mice compared to WT mice. In both cases, the fold change
is shown in each pair of columns for the given genes.
Figure 4 - Confirmation of selected gene expression levels by semi-quan-
titative RT-PCR. Nine genes with different expression patterns identified
by microarray analysis were selected for validation of the microarray as-
say. A. PCR products from quantitative RT-PCR. B. Changes in expres-
sion levels measured by microarray and RT-PCR. The Y-axis shows the
ratio (expressed as fold change) of gene expression between VC-treated
sfx mice and normal (WT) mice for each gene and technique used.genesintheliverofVC-treatedsfxmiceresultsinincreased
oxidative stress.
Discussion
The results described here suggest that attention
shouldbepaidtohowmuchVCissuppliedinstudiesusing
Gulo-deleted mice. Our findings also raise questions about
the influence that insufficient supplementary VC in Gulo-
deletedmicehasonstudiesusingthesemice.Thegrowthof
sfx mice given 500 mg of VC/mL in their drinking water
was essentially normal. Of the various organs examined,
only the spleen of sfx mice showed a significant difference
in weight compared to WT. Another relevant question that
this phenotype raises is whether lower than normal VC
levels compromise the immune system. In a study using
chickens, Wu et al. (2000) discovered that dietary supple-
mentation with ascorbic acid ameliorated the
immunosuppression caused by IBDV vaccination and im-
proved humoral and cellular immune responses. We have
previously shown that sfx mice have a much lower number
of white blood cells compared to normal controls (0.83 x
10
9vs.2.16x10
9)(Plantingaetal.,2007).Thesestudiesin-
dicate the need for a careful investigation of the influence
of a VC deficiency on the immune system.
The down-regulation of several genes in the MAPK
pathway pointed to a potential molecular mechanism for
theantioxidantactivityofVC.Theup-regulationofseveral
liver- specific and/or highly expressed genes was alarming
in view of the serious concern that a lack of VC in early
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Figure5-TranscriptomicmappingoflocithatregulateGuloexpression.A.Wholegenomemappingrevealedlocionchromosomes2and18.B.Critical
regions of chromosome 18 that regulate Gulo gene expression.childhood may result in liver damage because of impair-
ment of the intrinsic defense system.
Our data also raise the question of whether VC
metabolismissimilarinhumansandmice,i.e.,arethepath-
ways involved in the metabolism of endogenous and exog-
enous VC different? The major pathways of VC metabo-
lism are probably similar in these two species, although
theremaybeminordifferences.Severalofthe269differen-
tially expressed genes identified in this study encode for
important proteins in oxidative pathways and liver metabo-
lism and were expressed at different levels in WT and
VC-treated mice. These findings support the notion of dif-
ferences in VC metabolism. Previously, in a study using
VC deficient mice, Lee et al. (2008) found that VC supple-
mentation does not protect VC-deficient mice from
Helicobacter pylori-induced gastritis and gastric prema-
lignancy, at either low or high levels of VC supplemen-
tation. In their study, the high level of VC supplementation
is 3,300 mg/L vitamin C in drinking water. As shown here
(Figure 1), VC-treated sfx mice at 500 mg/L had a lower
hepatic concentration of VC than WT mice, indicating that
VC supplementation does not correct all of the changes in
gene expression caused by a lack of endogenous VC. An
obvious explanation for this could be that endogenous VC
production in wild type mice is stimulated when required
whereas in humans, VC availability is dependent on the
food intake and may not reach tissues as rapidly as in mice.
Together, these considerations suggest that VC-deficient
mice provide a better model of the human condition than
wild type mice.
Theidentificationofamajorlocusandofthreeoxida-
tive genes within this locus further emphasizes the impor-
tance of VC and Gulo in attenuating oxidative stress. In
particular, transthyretin is a soluble human plasma protein.
Inflammatory and oxidative stress pathways are triggered
by fibrillar and non-fibrillar Transthyretin (TTR) deposits
(Saraiya 2003; Sousa et al., 2004; Tiahou et al., 2004;
Maleknia et al., 2006). Aquaporin 4 has been implicated in
astrocyte swelling during hepatic encephalopathy in re-
sponse to oxidative stress and changes in the mitochondrial
permeability transition (Bienert et al., 2007; Rama and
Norenberg, 2007). Further studies of the relationship be-
tween Gulo, Ttr, and Aquaporin 4 may shed light on the
mechanism by which VC regulates oxidative stress.
Animals lacking the Gulo gene would appear to be
good models for understanding the molecular mechanisms
ofVCinhumanssincethelatteralsolackthisgene.Selman
et al. (2006) reported that life-long supplementation with
VC does not affect the extent of oxidative damage or life-
span in C57BL/6 mice. However, it is unclear to what ex-
tent these findings with C57BL/6 mice can be extended to
humans. If humans lack Gulo and cannot synthesize VC
then how can true comparisons be made between humans
andmicesinceWTmicehaveGuloandconsequentlynatu-
rally produce VC? For this reason, comparative studies in-
volving humans and rodents should use Gulo-deficient ro-
dents in order to mimic the human condition as closely as
possible.
The sfx mouse is not the first mouse model that lacks
the Gulo gene, but it is the first such model to be used in a
microarray analysis of the effects of VC deficiency on
hepatic antioxidant function. Earlier mouse Gulo mutation
models were used to examine other aspects of the biology
of VC (Horio et al., 2001; Hasan et al., 2004; Telang et al.,
2007),partlybecauseoftheinvestigatorsdifferentresearch
interests and partly because of the unavailability of high
throughput gene expression technologies at the time of
these studies. With the introduction of new technologies
and of genomic and bioinformatics tools many previously
accepted aspects of the biology of VC may need to be
re-examinedinordertoconfirmtheirvalidityandintroduce
modifications where necessary.
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